Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,2-didocos-13-enoyl Phoshatidylcholine
1. 51779-95-4
2. L-dierucoyl Lecithin
3. Dierucoyllecithin
4. Depc, L-
5. Depc, R-
6. 1,2-di13-cis-docosenoyl-sn-glycero-3-phosphocholine
7. 1,2-dierucoyl-phosphatidylcholine, R-
8. 1,2-dierucoyl-sn-glycerol-3-phosphorylcholine
9. Pc(22:1/22:1)
10. Dierucoyl-l-a-glycerophosphorylcholine
11. 1,2-di-(13z-docosenoyl)-sn-glycero-3-phosphocholine
12. Pc(22:1(13z)/22:1(13z))
13. 1z951826b6
14. 1,2-dierucoyl-sn-glycero-3-phosphatidylcholine
15. [(2r)-2,3-bis[[(z)-docos-13-enoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl Phosphate
16. 3,5,9-trioxa-4-phosphahentriacont-22-en-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-(((13z)-1-oxo-13-docosen-1-yl)oxy)-, Inner Salt, 4-oxide, (7r,22z)-
17. Dierucoylphosphatidylcholine
18. 3,5,9-trioxa-4-phosphahentriacont-22-en-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-[[(13z)-1-oxo-13-docosen-1-yl]oxy]-, Inner Salt, 4-oxide, (7r,22z)-
19. Unii-1z951826b6
20. Dierucoyl Phosphatidylcholine
21. Schembl178155
22. 22:1 (cis) Pc
23. Dtxsid401345798
24. Phosphatidylcholine(22:1/22:1)
25. 76420-81-0
26. Bca77995
27. Gpcho(22:1/22:1)
28. Gpcho(22:1n9/22:1n9)
29. Gpcho(22:1w9/22:1w9)
30. Lmgp01011110
31. Mfcd00674315
32. Hy-w127499
33. Pc(22:1n9/22:1n9)
34. Pc(22:1w9/22:1w9)
35. Phosphatidylcholine(22:1n9/22:1n9)
36. Phosphatidylcholine(22:1w9/22:1w9)
37. 1,2-didocos-13-enoyl Phoshatidylcholine
38. Bp-26302
39. 1,2-dierucoyl-rac-glycero-3-phosphocholine
40. Dierucoyl-l-.alpha.-glycerophosphorylcholine
41. Cs-0185727
42. D5319
43. T70993
44. Q27253299
45. 1,2-dierucoyl-sn-glycero-3-phosphocholine, >=98.0% (tlc)
46. 22:1 (cis) Pc, 1,2-dierucoyl-sn-glycero-3-phosphocholine, Powder
47. (r)-2,3-bis(erucoyloxy)propyl [2-(trimethylammonio)ethyl] Phosphate
48. 1,2-dierucoyl-sn-glycero-3-phosphocholine Pound>>1,2-di(cis-13-docosenoyl)-sn-glycero-3-phosphocholine
49. 3,5,9-trioxa-4-phosphahentriacont-22-en-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxo-13-docosenyl)oxy)-, Hydroxide, Inner Salt, 4-oxide, (r)-
50. 3,5,9-trioxa-4-phosphahentriacont-22-en-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-[(1-oxo-13-docosenyl)oxy]-, Inner Salt, 4-oxide, [r-(z,z)]-
51. 3,5,9-trioxa-4-phosphahentriacont-22-en-1-aminium,4-hydroxy-n,n,n-trimethyl-10-oxo-7-[[(13z)-1-oxo-13-docosen-1-yl]oxy]-,innersalt,4-oxide,(7r,22z)-
1. Depc
2. Depc Api
Molecular Weight | 898.3 g/mol |
---|---|
Molecular Formula | C52H100NO8P |
XLogP3 | 18.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 50 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 111 |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 1100 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
79
PharmaCompass offers a list of DEPC API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right DEPC manufacturer or DEPC supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred DEPC manufacturer or DEPC supplier.
PharmaCompass also assists you with knowing the DEPC API Price utilized in the formulation of products. DEPC API Price is not always fixed or binding as the DEPC Price is obtained through a variety of data sources. The DEPC Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dierucoyl-L-.alpha.-glycerophosphorylcholine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dierucoyl-L-.alpha.-glycerophosphorylcholine, including repackagers and relabelers. The FDA regulates Dierucoyl-L-.alpha.-glycerophosphorylcholine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dierucoyl-L-.alpha.-glycerophosphorylcholine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dierucoyl-L-.alpha.-glycerophosphorylcholine supplier is an individual or a company that provides Dierucoyl-L-.alpha.-glycerophosphorylcholine active pharmaceutical ingredient (API) or Dierucoyl-L-.alpha.-glycerophosphorylcholine finished formulations upon request. The Dierucoyl-L-.alpha.-glycerophosphorylcholine suppliers may include Dierucoyl-L-.alpha.-glycerophosphorylcholine API manufacturers, exporters, distributors and traders.
click here to find a list of Dierucoyl-L-.alpha.-glycerophosphorylcholine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dierucoyl-L-.alpha.-glycerophosphorylcholine DMF (Drug Master File) is a document detailing the whole manufacturing process of Dierucoyl-L-.alpha.-glycerophosphorylcholine active pharmaceutical ingredient (API) in detail. Different forms of Dierucoyl-L-.alpha.-glycerophosphorylcholine DMFs exist exist since differing nations have different regulations, such as Dierucoyl-L-.alpha.-glycerophosphorylcholine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dierucoyl-L-.alpha.-glycerophosphorylcholine DMF submitted to regulatory agencies in the US is known as a USDMF. Dierucoyl-L-.alpha.-glycerophosphorylcholine USDMF includes data on Dierucoyl-L-.alpha.-glycerophosphorylcholine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dierucoyl-L-.alpha.-glycerophosphorylcholine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dierucoyl-L-.alpha.-glycerophosphorylcholine suppliers with USDMF on PharmaCompass.
Dierucoyl-L-.alpha.-glycerophosphorylcholine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dierucoyl-L-.alpha.-glycerophosphorylcholine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dierucoyl-L-.alpha.-glycerophosphorylcholine GMP manufacturer or Dierucoyl-L-.alpha.-glycerophosphorylcholine GMP API supplier for your needs.
A Dierucoyl-L-.alpha.-glycerophosphorylcholine CoA (Certificate of Analysis) is a formal document that attests to Dierucoyl-L-.alpha.-glycerophosphorylcholine's compliance with Dierucoyl-L-.alpha.-glycerophosphorylcholine specifications and serves as a tool for batch-level quality control.
Dierucoyl-L-.alpha.-glycerophosphorylcholine CoA mostly includes findings from lab analyses of a specific batch. For each Dierucoyl-L-.alpha.-glycerophosphorylcholine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dierucoyl-L-.alpha.-glycerophosphorylcholine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dierucoyl-L-.alpha.-glycerophosphorylcholine EP), Dierucoyl-L-.alpha.-glycerophosphorylcholine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dierucoyl-L-.alpha.-glycerophosphorylcholine USP).